Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00398502 · ClinicalTrials.gov registry record · Phase 1
Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone
A Phase 1 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00398502 is a Phase 1 study that has completed, run by Bausch Health Americas.
The verdict
NCT00398502, a Phase 1 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
Primary: To determine the relative bioavailability of MOA-728, an investigational drug, administered orally in both the capsule and tablet formulations to methadone maintenance subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally and subcutaneously to methadone maintenance subjects using the oral-cecal transit time.
Interventions
- DRUG MOA-728
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-10 |
| Est. Completion | 2006-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00398502
The ClinicalTrials.gov registry entry for NCT00398502 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MOA-728 is the first listed.
NCT00398502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00398502 about?
NCT00398502 is a clinical study titled "Comparisons Of The Bioavailability And Pharmacodynamics Of Various Formulations Of MOA-728 In Subjects On Methadone". Primary: To determine the relative bioavailability of MOA-728, an investigational drug, administered orally in both the capsule and tablet formulations to methadone maintenance subjects.Secondary: To assess the pharmacodynamic effect of MOA-728 administered both orally and subcutaneously to methadon...
What is the current status of trial NCT00398502?
This trial is currently completed. It is a Phase 1 study. The study started on 2006-10. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00398502?
The interventions under investigation include: MOA-728 (DRUG).
Who is sponsoring clinical trial NCT00398502?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.